Hiroki Terazono

617 total citations
8 papers, 498 citations indexed

About

Hiroki Terazono is a scholar working on Clinical Biochemistry, Molecular Biology and Genetics. According to data from OpenAlex, Hiroki Terazono has authored 8 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Hiroki Terazono's work include Metabolism and Genetic Disorders (6 papers), Blood disorders and treatments (3 papers) and Genomics and Rare Diseases (2 papers). Hiroki Terazono is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Blood disorders and treatments (3 papers) and Genomics and Rare Diseases (2 papers). Hiroki Terazono collaborates with scholars based in Japan and Canada. Hiroki Terazono's co-authors include Takeyori Saheki, Keiko Kobayashi, Stephen W. Scherer, Ikuko Kondo, David S. Sinasac, Laila Begum, Ryuki Hirano, Mikio Iijima, Andrew P. Boright and Michael A. Crackower and has published in prestigious journals such as Nature Genetics, FEBS Letters and Human Mutation.

In The Last Decade

Hiroki Terazono

8 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroki Terazono Japan	7	428	255	133	112	107	8	498
Ayako Tabata Japan	9	415 1.0×	141 0.6×	213 1.6×	197 1.8×	75 0.7×	10	465
Takeyori Saheki Japan	7	267 0.6×	119 0.5×	121 0.9×	117 1.0×	54 0.5×	16	334
Soledad Kleppe United States	8	160 0.4×	153 0.6×	57 0.4×	54 0.5×	51 0.5×	12	333
Gaetano Sabetta Italy	10	402 0.9×	340 1.3×	174 1.3×	36 0.3×	62 0.6×	11	631
U. van Haelst Netherlands	4	281 0.7×	324 1.3×	26 0.2×	63 0.6×	37 0.3×	7	467
A. Green United Kingdom	11	305 0.7×	179 0.7×	81 0.6×	41 0.4×	120 1.1×	28	415
W.G. Ng United States	10	247 0.6×	119 0.5×	137 1.0×	17 0.2×	98 0.9×	27	442
Vassiliki Konstantopoulou Austria	14	344 0.8×	288 1.1×	92 0.7×	20 0.2×	42 0.4×	33	484
Vladimir Sarnavka Croatia	10	179 0.4×	272 1.1×	48 0.4×	30 0.3×	41 0.4×	25	445
Monique Mathieu France	10	291 0.7×	264 1.0×	40 0.3×	30 0.3×	27 0.3×	13	450

Countries citing papers authored by Hiroki Terazono

Since Specialization

Citations

This map shows the geographic impact of Hiroki Terazono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Terazono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Terazono more than expected).

Fields of papers citing papers by Hiroki Terazono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Terazono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Terazono. The network helps show where Hiroki Terazono may publish in the future.

Co-authorship network of co-authors of Hiroki Terazono

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Terazono. A scholar is included among the top collaborators of Hiroki Terazono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Terazono. Hiroki Terazono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Horiuchi, Masahisa, et al.. (1999). Pyruvate dehydrogenase kinase 4 mRNA is increased in the hypertrophied ventricles of carnitine‐deficient juvenile visceral steatosis (JVS) mice. BioFactors. 10(2-3). 301–309. 13 indexed citations

2.

Kobayashi, Keiko, David S. Sinasac, Mikio Iijima, et al.. (1999). The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nature Genetics. 22(2). 159–163. 326 indexed citations

3.

Kobayashi, Keiko, et al.. (1997). A novel gene suppressed in the ventricle of carnitine‐deficient juvenile visceral steatosis mice¹. FEBS Letters. 408(2). 221–224. 19 indexed citations

4.

Kobayashi, Keiko, et al.. (1997). Mutations and DNA diagnoses of classical citrullinemia. Human Mutation. 9(3). 250–259. 28 indexed citations

5.

Kobayashi, Keiko, et al.. (1997). Mutations and DNA diagnoses of classical citrullinemia. Human Mutation. 9(3). 250–259. 3 indexed citations

6.

Kobayashi, Keiko, et al.. (1995). Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia. Human Genetics. 96(4). 454–63. 48 indexed citations

7.

Nakata, Masanori, et al.. (1995). Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult‐onset type II citrullinemia. FEBS Letters. 372(1). 69–73. 25 indexed citations

8.

Kobayashi, Katsuya, Nazma Shaheen, Hiroki Terazono, & Takeyori Saheki. (1995). Mutations in argininosuccinate synthetase mRNA in Japanese patients, causing classical citrullinemia.. PubMed. 56(1). 356–356. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact